Grants for Public and State controlled institutions of higher education - Health

This grant provides funding for Ohio-based public universities, nonprofit organizations, and government entities to conduct a two-year research study on the health impacts and benefits of high-THC cannabis and hemp-derived products.

This grant provides funding for a Data Coordinating Center to support multi-site clinical trials focused on natural products, requiring collaboration with a Clinical Coordinating Center and emphasizing diverse perspectives in research.

This funding opportunity provides financial support to state agencies, local governments, and nonprofit organizations to improve the efficiency and user experience of the Supplemental Nutrition Assistance Program through modern technology and streamlined processes.

This funding opportunity provides support for U.S. institutions to create short-term research training programs for health professional and graduate students interested in biomedical, behavioral, or clinical research careers.

This program provides quick funding to researchers at North Carolina universities and nonprofit institutes to develop innovative life sciences projects that show strong commercial potential.

This grant provides funding to researchers for developing detailed study protocols and procedures for large-scale vision research projects, without generating new data on interventions.

The National Center for Advancing Translational Sciences (NCATS) will award Institutional Research Career Development (K12) programs through the Clinical and Translational Science Awards (CTSA).The National Center for Advancing Translational Sciences (NCATS) will award Institutional Research Career Development (K12) programs through the Clinical and Translational Science Awards (CTSA). The purpose of this Funding Opportunity Announcement (FOA) is to encourage institutions to propose creative and innovative institutional research career development programs designed to prepare an outstanding heterogeneous pool of promising later stage postdoctoral fellows and junior faculty scholars in clinical and translational science who have made a commitment to independent research careers (i.e., tenure-track or equivalent faculty positions), and to facilitate their timely transition to more advanced support mechanisms, e.g., K08, K23, R01, R03, etc. Applicants must submit both a UM1 application to PAR-21-293: Clinical and Translational Science Award and a K12 application to this FOA. This Funding Opportunity Announcement (FOA) allows appointment of Scholars (K12) proposing to serve as the lead investigator of an independent clinical trial; or proposing a separate ancillary clinical trial; or proposing to gain research experience in a clinical trial led by another investigator, as part of their research and career development

This funding opportunity supports the creation of mentoring networks that provide professional development and career guidance for graduate students, postdoctoral scholars, and early-career researchers in mental health, helping them advance towards independent research careers.

This grant provides funding to educational institutions and organizations to develop programs that support individuals from diverse backgrounds in pursuing careers in biomedical and behavioral research through skills development, research experiences, and mentoring.

This grant provides access to valuable biological samples and data for researchers studying common and serious health conditions, such as diabetes and kidney diseases, to support innovative research and development of new treatments.

Small research (R03) grants provide flexibility for initiating studies which are generally for preliminary or short-term projects. These grants are non-renewable. Some examples of the types of projects that R03 research supports include: Pilot or feasibility studies Secondary analysis of existing data Small, self-contained research projects Development of research methodology Development of new research technology The AHRQ small grant is a mechanism for supporting discrete, well-defined projects that realistically can be completed within two years (or less) within the budget constraints of the mechanism. Because the research strategy section of the application is limited to 6 pages, an R03 grant application may not contain the same level of detail as that found in an R01 application. Accordingly, appropriate justification for the proposed work can be provided through literature citations, data from other sources, or from investigator-generated data. Preliminary data are not required, particularly in applications proposing pilot or feasibility studies. The Small Research Grant (R03) is an award made by AHRQ to an institution/organization to support a discrete health services research project. The R03 research strategy proposed by the applicant institution/organization must be related to the mission and research interests of AHRQ, which are detailed below. Although the PD/PI is responsible for conducting and supervising the research, the actual applicant is the research institution/organization legally accountable for the performance of the award and the expenditure of funds. AHRQ Mission and Research Areas of Interest: The AHRQ mission is to produce evidence to make health care safer, higher quality, more ac­cessible, equitable and affordable, and to work with HHS and other partners to make sure that the evidence is understood and used. Within this mission, AHRQ’s specific priority areas of focus are: Research to improve health care patient safety. Harnessing data and technology to improve health care quality and patient outcomes and to provide a 360-degree view of the patient. Research to increase accessibility and affordability of health care by examining innovative market approaches to care delivery and financing. Research to Improve Health Care Patient Safety Patient safety is defined as the freedom from accidental or preventable injury produced by health care as well as the practices that create a safe environment of care. The ultimate goal of AHRQ-supported Patient Safety research is to improve the safety of health care delivery. Patient safety research initiatives that lead to this goal can be considered in three different stages: Identification of risks, hazards, and patient harm. Design, implementation, dissemination and spread, and evaluation of interventions to improve patient safety. Establishment of strategies to sustain patient safety improvements such as just culture, incident/event reporting, measurement, monitoring, and surveillance. AHRQ's Patient Safety Research Program: (1) identifies specific areas of focus through targeted grant funding announcements (i.e., Program Announcements, Requests for Applications, and Special Emphasis Notices) and (2) encourages investigators to utilize the Agency's general funding announcements to apply this research framework in response to other patient safety threats and opportunities for improvement. The Patient Safety Portfolio will support research projects to create new knowledge by identifying the risks, hazards, and harm encountered by patients as a result of health care. The Portfolio will also support projects that mitigate those risks, hazards, and harm including the design, implementation and evaluation of strategies (patient safety practices) and the adaptation, refinement, and sustainment of those strategies. These initiatives are part of the Agency's overall mission to improve the quality of health care. AHRQ encourages an interdisciplinary, systems science patient safety approach. In addition to health services research, perspectives from organizational theory, human factors, industrial engineering, facilities design, education, and other disciplines can be incorporated in research plans. Projects may address important topics such as: the surveillance, measurement, detection, and reporting of patient safety events; the impact of human performance, work flow, and working conditions on patient safety; the patients' role and contribution to patient safety; health care safety culture, leadership, communication, teamwork, and simulation; prevention and control of healthcare-associated infections (HAIs); diagnostic safety and quality; the safe use of medical devices and medications, including safely prescribing opioids; the role of Patient Safety Organizations; and the challenges inherent in transitions of care in the same setting and between settings and handoffs between health care providers. Research related to the prevention and control of HAIs is an instructive example of AHRQ’s Patient Safety research interests. AHRQ supports research whose short-term or long-term aim is to develop improved methods for preventing HAIs and to develop effective implementation strategies for HAI prevention in all health care settings. Accordingly, AHRQ’s foci of interest in HAI research are the following broad areas: Determination of the clinical efficacy and effectiveness of preventive interventions, including unintended adverse consequences. Characterization and assessment of relevant epidemiological aspects of HAIs, including but not limited to patient risk factors, clinical presentation, and sources of antibiotic-resistant organisms involved in the development of HAIs. Demonstration, dissemination, and evaluation of strategies and approaches for prevention and reduction of HAIs. Research regarding adoption and implementation (including sustainment, spread, and scale-up) of evidence-based approaches for prevention of HAIs. The HAI research portfolio also encompasses generation of knowledge for combating antibiotic resistant bacteria. AHRQ is interested in studies to promote appropriate antibiotic use, reduce the transmission of resistant bacteria, and prevent HAIs in the first place. The last contributes to antibiotic stewardship by avoiding the need for antibiotic therapy and precludes the possibility of a resistant infection. Clinical investigations that seek to establish the efficacy or effectiveness of preventive interventions, as noted above, typically involve a comparison of the intervention in question to routine care or, less frequently, to a placebo (when the latter is ethical). Such clinical studies are included in the scope of AHRQ’s HAI research portfolio. The HAI Portfolio does not fund comparisons of two interventions of known efficacy or effectiveness to determine which is more efficacious or effective. Such studies are comparative effectiveness research, which is more appropriately funded by other funding sources. The Portfolio supports research in all health care settings including the hospital, long-term care, ambulatory care, home health care, pharmacy, and transitions of care between settings. Patient safety research involves many stakeholder groups including patients, families, clinicians, non-clinical health care staff, policymakers, payers, and health care organizations including providers and accreditors, local and State governments, and the Federal Government, Patient Safety Organizations, and many others. Projects in this area may also address patient characteristics that might influence the risk of experiencing a patient safety event, for example, attributes of AHRQ's priority populations that can impact patient safety and address strategies to address barriers to safe care. Harnessing Data and Technology To Improve Health Care Quality and Patient Outcomes and To Provide a 360-Degree View of the Patient AHRQ is interested in research to: advance the methods of evidence synthesis to ensure scientific rigor and unbiased reviews, make evidence-based recommendations on clinical preventive services, conduct research on how health information technology can improve the quality of health care, advance the science of clinical practice improvement, evaluate and support innovative models of practice transformation in primary care and other ambulatory settings, and facilitate communities of learning to promote the implementation of evidence for practice improvement. Further, AHRQ is interested in studying and improving upon the process by which health systems and ambulatory care practices select evidence to implement and how to determine what strategies are used to implement the evidence into everyday practice. The study of implementation strategies and processes is critical because interventions developed in the context of publically funded efficacy and effectiveness trials are rarely scalable without adaptations to specific settings and additional tools and guidance to support uptake and implementation. AHRQ is also interested in research that advances whole-person, 360-degree care especially those with multiple chronic conditions and/or socioeconomic disadvantage. Whole person, 360-degree care is defined as the coordination of health, behavioral health, intellectual/developmental disabilities, and social services in a person-centered manner with the goals of improved health outcomes and more efficient and effective use of resources in the context of people’s lives and the communities they live in. Emphasis is on the orientation of the health care team to consider all domains of a person’s life when assessing and addressing needs. The following lists examples of AHRQ research priorities: Improving health care quality outcomes by providing integrated, coordinated whole-person, 360-degree care to optimize individual and population health outcomes: Generation of knowledge about how clinical teams can most effectively elicit and use a patient’s values; preferences; and personal, social, and clinical context to formulate and use plans of care in partnership with patients, caregivers, and families. Preferences, values, and context may be specific to the situation and also can change over time. Therefore, proposals that address how the process of care planning and the care plans themselves will identify and respond to the specific and dynamic nature of patients’ circumstances are of interest. Development of information and data to create/foster/support partnerships and linkages between health care and human service systems (community-based organizations and public health) to improve whole-person care. These could be focused on improving care coordination and strengthening care transitions, ensuring that care is fully integrated to support the whole person and family. Improvement of health care quality through the use of information systems and data resources that both provide meaningful clinical decision support to health care professionals and patients and families at the point of care and that capture important actions and outcomes of health care to increase evidence on effective practices and support clinical and organizational improvement. Implementation of clinical prevention guidelines into learning health systems with innovative ways to include patients’ preferences and values in order to empower whole person-centered care. Development and study of models of shared decision making that are tailored to the needs of disadvantaged populations. Development of whole-person care research to improve health and health services efforts in persons with multiple chronic conditions. Development, implementation, and evaluation of models of primary care for individuals with complexity, including multiple chronic conditions, disability, and socioeconomic disadvantage that improve individual and population health while reducing disparities. Implement research findings in order to accelerate the spread of evidence-based practices by: Implementation of evidence-based approaches to identify, understand, and overcome barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, tools, policies, and guidelines. Research on de-implementation of the use of health system procedures and clinical practices that are ineffective, have been prematurely widely adopted, or are harmful or wasteful. Development of a parsimonious set of meaningful measures to evaluate implementation and impact of whole-person care. Development of innovative ways to use data and health information technology (IT) in primary care practices in order to increase uptake and implementation of preventive services, especially those involving behavioral change (e.g. obesity prevention, substance use prevention). Development of methods underlying the fields of evidence synthesis, stakeholder and patient engagement, decision making, and practice improvement. Accelerating the ability of health care organizations to evolve as learning health systems that effectively apply data and evidence to improve patient outcomes by: Synthesizing, translating, and communicating complex scientific evidence to facilitate informed care planning and health care decision making by patients, families, and health care professionals at the individual level and informed policy decision making at the health system and population level. Discovering, testing, and spreading methods and strategies for health care practice improvement to improve health care quality, including accelerating the sustainable implementation of evidence-based practice. AHRQ has particular interest in practice improvement in primary care and ambulatory settings. Demonstrating the effectiveness of synthesizing, translating, and communicating complex scientific evidence to facilitate informed care planning and health care decision making by patients, families, and health care professionals at the individual level and informed policy decision making at the health system and population level. Research to Increase Accessibility and Affordability of Health Care by Examining Innovative Market Approaches to Care Delivery and Financing Producing evidence that can be used to increase the affordability and efficiency of health care for all Americans is a major AHRQ priority. Potential research areas and questions include but are not limited to the following: Reducing Cost Growth: In order to make health care more affordable, we must understand the drivers of those costs and their growth, as well as the relationship between cost and quality. Comparing Performance of Systems and Providers: AHRQ is interested in research that will allow comparison of delivery system and provider performance by health care stakeholders such as consumers, providers, payers, insurers, and policymakers. Incentives for Improving Performance: Public and private payers have provided a variety of financial and nonfinancial incentives to improve the performance of health care providers and systems. AHRQ is interested in research on the impacts of these changes—both intended and otherwise—as well as how to improve incentive programs. Interventions to Improve Performance: While alignment with external incentives is very important, it is the provider or system that implements interventions to increase performance. AHRQ is interested in research on how interventions to improve quality or cost are best implemented within and spread across providers and systems.

This grant provides funding to community-based organizations to develop postdoctoral training programs for dentists focused on improving oral health care access in rural and underserved areas.

The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome. This Funding Opportunity Announcement (FOA) invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in Down syndrome. This initiative seeks applications that are intended to facilitate Down syndrome research by enabling efficient and effective movement of candidate therapeutics or diagnostics towards clinical trials for Down syndrome and its co-occurring conditions, and to increase their likelihood of success through development and testing of biomarkers and clinical outcome assessment measures, development and testing of novel trial methods and recruitment strategies, or by defining the presentation and course of the co-occurring conditions in individuals with Down syndrome to enable the design of future clinical trials.

This grant provides funding to U.S.-based healthcare organizations to improve the care and outcomes for bladder cancer patients through collaborative, multi-disciplinary approaches.

Ball Brothers Foundation offers General Grants to support organizations operating within Indiana, with a strong focus on East Central Indiana and the Muncie/Delaware County area. These grants, ranging from $5,000 to $100,000, aim to fund capacity-building initiatives, innovative approaches for community needs, specific program/project initiatives, general operating support, and seed money for new endeavors. Grant renewed every year. Grant Round 2 Annual deadlines: September 1st (preliminary application July 15th)

This funding opportunity provides financial support to exceptional clinician scientists who contribute to the development and implementation of NCI clinical trials, ensuring their continued involvement in cancer research without being principal investigators on research project grants.

This grant provides funding for research on how HIV and substance use affect placental health and maternal outcomes, targeting a wide range of institutions and researchers focused on these critical health issues.

This grant provides funding for research projects that explore how sex hormones affect HIV progression and substance use disorders, aiming to develop new therapeutic strategies for these interconnected health issues.

The Rural Maryland Prosperity Investment Fund (RMPIF) aims to elevate the standard of living in rural Maryland to or beyond statewide averages by 2030, while simultaneously preserving the unique cultural heritage and rural way of life. The fund, overseen by the Rural Maryland Council, provides targeted investments in economic and community development programs. This aligns with a broader mission to encourage entrepreneurial activity, foster a balanced economy, and relieve unemployment and underemployment in rural areas, ultimately promoting the overall health and welfare of rural residents across the State. RMPIF targets all rural counties in Maryland, benefiting local governments, higher education institutions, regional councils, and 501(c)(3) nonprofit organizations serving rural constituencies. The core impact goal is to facilitate sustainable rural development by enabling these organizations to leverage additional non-state resources. Key priorities include the retention of valuable farm and forest land, promotion of intergovernmental and public-private partnerships, enhancement of essential infrastructure (housing, transportation, water, wastewater, broadband), and support for rural commercial center redevelopment and community revitalization efforts. The program's expected outcomes include increased entrepreneurial activity and commerce, a reduction in unemployment and underemployment, the productive use of farm and forest land, and improved infrastructure and services in rural areas. Measurable results for Fiscal Year 2025 include a State budget of $1,500,000 in General Funds specifically allocated for the entrepreneurship portion of the RMPIF program. The fund's theory of change posits that strategic investments and collaborative efforts will lead to a more prosperous, sustainable, and equitable future for rural Maryland, directly contributing to the well-being and economic stability of its residents. Eligible expenditures for RMPIF include salaries and wages, administrative costs (construction, leasing, renovation of buildings, purchase/rental of vehicles, equipment), and reasonable meal costs with justification. Administrative expenses, however, are capped at 25% of the grant request, and indirect administrative costs at 10%. Acquisition of land is not an eligible expense. Applicants are strongly encouraged to include a statement on sustainability for future years, ensuring the long-term impact and viability of the funded initiatives.

This funding opportunity supports research projects that develop and test innovative strategies to improve cancer screening and preventive services for populations facing health disparities, such as racial and ethnic minorities, low-income groups, and rural communities.